Business Wire

BioFire Diagnostics, Inc. Announces Issuance of U.S. Patent for the FilmArray® System

SALT LAKE CITY--(BUSINESS WIRE)--BioFire Diagnostics, Inc., today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 8,394,608 covering the company’s FilmArray ...
Firefighter Nation

BioFire Awarded Next Generation Diagnostics System Contract

SALT LAKE CITY, Utah (March 26, 2013) — BioFire Diagnostics, Inc. today announced that it has signed a competitive prototyping contract with the Department of the Army for Increment 1 of the Next ...
technologynetworks

bioMérieux Makes a Significant Acquisition in Molecular Biology in the U.S.

bioMérieux has announced that it has entered into an agreement to acquire BioFire Diagnostics Inc., a privately held U.S.-based company specialized in molecular biology. BioFire invented, manufactures ...
The Victoria Advocate

Acupath Laboratories Inc. Launches the BioFire® FilmArray® Gastrointestinal Pathogen (GI) Panel

PLAINVIEW, N.Y., Sept. 7, 2023 /PRNewswire/ -- Acupath Labs a leading provider of sub-specialized anatomic and molecular pathology services, launches the BioFire ® FilmArray ® GI Panel, a FDA-cleared ...
Firehouse

FDA Clears Idaho Technology's FilmArray Instrument

SALT LAKE CITY, UT - Idaho Technology, Inc. (ITI) announced today that the U.S. Food and Drug Administration has issued a 510(k) clearance for the FilmArray instrument and the FilmArray Respiratory ...
Nasdaq

bioMérieux: BIOFIRE® Respiratory Panel 2.1 (RP2.1) with SARS-CoV-2 Obtains FDA Emergency Use Authorization

MARCY L’ÉTOILE, France--(BUSINESS WIRE)-- Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, today announced that BioFire Diagnostics, its subsidiary ...
PE Hub

BioFire Diagnostics Ink $25M

BioFire Diagnostics Inc. has raised $25 million in new funding from New York-based Athyrium Opportunities Fund. The money will be used to help commercialize the company’s “FilmArray” diagnostic ...